Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MBA Early Feasibility Study

NCT: NCT07564375 · RECRUITING

NCT IDNCT07564375
StatusRECRUITING
Start Date2026-09-02
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

The MBA 25-04 study is a prospective, multicenter, non-randomized, single-arm, early feasibility study designed to assess the initial safety of the MBA device through five years following the index endovascular procedure.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑